Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

18 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

NCT01478685

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations: Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States

University of California, San Francisco San Francisco, California, United States

Indiana University Cancer Center Indianapolis, Indiana, United States

Karmanos Cancer Institute Detroit, Michigan, United States

View all 13 locations

Completed

NCT02300610

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States

Completed

NCT01529411

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, +6 more
Locations: Hospital General de Elda Virgen de la Salud Elda, Alicante, Spain

ICO-Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain

ICO-Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Fundació Althaia Manresa, Barcelona, Spain

View all 20 locations

Completed

NCT02014337

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +39 more
Locations: ACRC/Arizona Clinical Research Center Inc. Tucson, Arizona, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Rita Nanda, MD Chicago, Illinois, United States

Completed

NCT00077688

Conditions: Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations: University of Maryland Medical Center/Greenbaum Cancer Center Baltimore, Maryland, United States

Cleveland Clinic Foundation Cleveland, Ohio, United States

University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States

Completed

NCT00001381

Conditions: Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +13 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

Completed

NCT00191971

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +10 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ibaraki, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kagoshima, Japan

Completed

NCT00101842

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +2 more
Locations: For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Dallas, Texas, United States